Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Adicionar filtros








Intervalo de ano
1.
Neuroscience Bulletin ; (6): 1427-1440, 2021.
Artigo em Chinês | WPRIM | ID: wpr-951952

RESUMO

Epilepsy is a brain condition characterized by the recurrence of unprovoked seizures. Recent studies have shown that complement component 3 (C3) aggravate the neuronal injury in epilepsy. And our previous studies revealed that TRPV1 (transient receptor potential vanilloid type 1) is involved in epilepsy. Whether complement C3 regulation of neuronal injury is related to the activation of TRPV1 during epilepsy is not fully understood. We found that in a mouse model of status epilepticus (SE), complement C3 derived from astrocytes was increased and aggravated neuronal injury, and that TRPV1-knockout rescued neurons from the injury induced by complement C3. Circular RNAs are abundant in the brain, and the reduction of circRad52 caused by complement C3 promoted the expression of TRPV1 and exacerbated neuronal injury. Mechanistically, disorders of neuron–glia interaction mediated by the C3–TRPV1 signaling pathway may be important for the induction of neuronal injury. This study provides support for the hypothesis that the C3–TRPV1 pathway is involved in the prevention and treatment of neuronal injury and cognitive disorders.

2.
Neuroscience Bulletin ; (6): 1427-1440, 2021.
Artigo em Inglês | WPRIM | ID: wpr-922652

RESUMO

Epilepsy is a brain condition characterized by the recurrence of unprovoked seizures. Recent studies have shown that complement component 3 (C3) aggravate the neuronal injury in epilepsy. And our previous studies revealed that TRPV1 (transient receptor potential vanilloid type 1) is involved in epilepsy. Whether complement C3 regulation of neuronal injury is related to the activation of TRPV1 during epilepsy is not fully understood. We found that in a mouse model of status epilepticus (SE), complement C3 derived from astrocytes was increased and aggravated neuronal injury, and that TRPV1-knockout rescued neurons from the injury induced by complement C3. Circular RNAs are abundant in the brain, and the reduction of circRad52 caused by complement C3 promoted the expression of TRPV1 and exacerbated neuronal injury. Mechanistically, disorders of neuron-glia interaction mediated by the C3-TRPV1 signaling pathway may be important for the induction of neuronal injury. This study provides support for the hypothesis that the C3-TRPV1 pathway is involved in the prevention and treatment of neuronal injury and cognitive disorders.


Assuntos
Animais , Camundongos , Astrócitos/metabolismo , Complemento C3/metabolismo , Epilepsia , Neurônios/patologia , Estado Epiléptico , Canais de Cátion TRPV/metabolismo
3.
Journal of Zhejiang University. Science. B ; (12): 955-960, 2020.
Artigo em Inglês | WPRIM | ID: wpr-880737

RESUMO

Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which first affected humans in China on December 31, 2019 (Shi et al., 2020). Coronaviruses generally cause mild, self-limiting upper respiratory tract infections in humans, such as the common cold, pneumonia, and gastroenteritis (To et al., 2013; Berry et al., 2015; Chan et al., 2015). According to the Report of the World Health Organization (WHO)-China Joint Mission on COVID-19 (WHO, 2020), the case fatality rate of COVID-19 increases with age, while the rate among males is higher than that among females (4.7% and 2.8%, respectively). Since an effective vaccine and specific anti-viral drugs are still under development, passive immunization using the convalescent plasma (CP) of recovered COVID-19 donors may offer a suitable therapeutic strategy for severely ill patients in the meantime. So far, several studies have shown therapeutic efficacy of CP transfusion in treating COVID-19 cases. A pilot study first reported that transfusion of CP with neutralizing antibody titers above 1:640 was well tolerated and could potentially improve clinical outcomes through neutralizing viremia in severe COVID-19 cases (Chen et al., 2020). Immunoglobulin G (IgG) and IgM are the most abundant and important antibodies in protecting the human body from viral attack (Arabi et al., 2015; Marano et al., 2016). Our study aimed to understand the aspects of plasma antibody titer levels in convalescent patients, as well as assessing the clinical characteristics of normal, severely ill, and critically ill patients, and thus provide a basis for guiding CP therapy. We also hoped to find indicators which could serve as a reference in predicting the progression of the disease.


Assuntos
Adulto , Idoso , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Anticorpos Neutralizantes/sangue , Anticorpos Antivirais/sangue , COVID-19/terapia , China , Imunização Passiva , Imunoglobulina G/sangue , Imunoglobulina M/sangue
4.
Chinese Journal of Medical Library and Information Science ; (12): 26-33, 2018.
Artigo em Chinês | WPRIM | ID: wpr-712453

RESUMO

Objective To comparatively analyze the the relationship between PLoS ALMs,Altmetrics score and the indications for assessing the academic level of individual articles and their efficiency for assessing the academic level of individual articles. Methods The relationship of the viewed, downloaded, discussed, recommended counts and frequency of citation with Altmetrics score, h index, academic track T and their efficiency for assessing a single pa-per were comparatively analyzed with PLoS Biology and PLoS Medicine as an example. Results The viewed, down-loaded and discussed papers were positively related with the frequency of citation and h index, the recommended papers were not related with the h index and academic track T, and the Altmetrics score was moderately related with the red, downloaded and discussed papers, and was weakly related with the frequency of citation. Conclusion PLoS ALMS is a multidimensional assessment. Only it is measured with several indications, can it demonstrate a work’s comprehensive strength.

5.
Chinese Journal of Applied Physiology ; (6): 504-507, 2015.
Artigo em Inglês | WPRIM | ID: wpr-254981

RESUMO

Laboratory animals and animal experiments are foundations and important support conditions for life sciences, especially for medical research. The animal experiments have drawn extensive attention from the society because of the ethical issue. This paper takes Wenzhou Medical University as an example to give a brief introduction to the ethical review about laboratory animals in the university so as to further draw attention and concerns from the public about the ethical issue of laboratory animals. We successively introduce its scientific projects, nurturing environment and ethical review of laboratory animals.


Assuntos
Animais , Experimentação Animal , Ética , Animais de Laboratório , Universidades
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA